Supreme Court justice Stephen Breyer, author of the well-known dissent in LabCorp v Metabolite expressing scepticism over the patent eligibility of diagnostic method claims, pressed the parties in Mayo v Prometheus today to better explain how the Court should determine when a law of nature has been sufficiently applied to make it patentable
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The model covers court-guided settlements, submissions-led determination of infringement and validity issues, and provides leeway for the court to determine a FRAND rate during negotiations